company background image
DP3 logo

Central Pharmaceutical No3 HNX:DP3 Stock Report

Last Price


Market Cap







21 Jun, 2024


Company Financials

Central Pharmaceutical Joint Stock Company No3

HNX:DP3 Stock Report

Market Cap: ₫1.4t

DP3 Stock Overview

Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.

DP3 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance6/6
Financial Health6/6

Central Pharmaceutical Joint Stock Company No3 Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Central Pharmaceutical No3
Historical stock prices
Current Share Price₫63,000.00
52 Week High₫80,800.00
52 Week Low₫53,920.00
11 Month Change0.80%
3 Month Change-10.89%
1 Year Change8.62%
33 Year Change36.36%
5 Year Change154.85%
Change since IPO650.00%

Recent News & Updates

Recent updates

Shareholder Returns

DP3VN PharmaceuticalsVN Market

Return vs Industry: DP3 underperformed the VN Pharmaceuticals industry which returned 9.9% over the past year.

Return vs Market: DP3 underperformed the VN Market which returned 12.1% over the past year.

Price Volatility

Is DP3's price volatile compared to industry and market?
DP3 volatility
DP3 Average Weekly Movement2.8%
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.8%
10% most volatile stocks in VN Market7.4%
10% least volatile stocks in VN Market2.8%

Stable Share Price: DP3 has not had significant price volatility in the past 3 months.

Volatility Over Time: DP3's weekly volatility (3%) has been stable over the past year.

About the Company


Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. It offers medicines from medicinal herbs, western medicines2, functional foods, and cosmetics products. Central Pharmaceutical Joint Stock Company No3 was founded in 1962 and is based in H

Central Pharmaceutical Joint Stock Company No3 Fundamentals Summary

How do Central Pharmaceutical No3's earnings and revenue compare to its market cap?
DP3 fundamental statistics
Market cap₫1.35t
Earnings (TTM)₫123.06b
Revenue (TTM)₫393.68b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DP3 income statement (TTM)
Cost of Revenue₫124.24b
Gross Profit₫269.44b
Other Expenses₫146.38b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)5.72k
Gross Margin68.44%
Net Profit Margin31.26%
Debt/Equity Ratio0.9%

How did DP3 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.